4.3 Article Proceedings Paper

Drug-induced prolongation of the QT interval: why the regulatory concern?

Journal

FUNDAMENTAL & CLINICAL PHARMACOLOGY
Volume 16, Issue 2, Pages 119-124

Publisher

BLACKWELL PUBLISHING LTD
DOI: 10.1046/j.1472-8206.2002.00082.x

Keywords

dose schedules; drug interactions; non-cardiac drugs; pharmacodynamic susceptibility; pharmacogenetics; QT interval; stereoselective toxicity; torsade de pointes

Ask authors/readers for more resources

The views expressed in this paper are those of the author and do not necessarily represent the views or the opinions of Medicines Control Agency, other regulatory authorities or any of their advisory committees.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available